Melodic Intonation Therapy — NCD 89 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 89 for melodic intonation therapy, effective March 7, 2026. Here's what changes for billing teams.

CMS melodic intonation therapy coverage policy under NCD 89 in the Medicare system is narrow by design — and if your speech-language pathology program treats aphasia, this modification is worth a close read. The policy covers melodic intonation therapy only for nonfluent aphasic patients who have not responded to conventional therapy. No specific CPT or HCPCS codes are listed in this modified policy. You'll bill this under the broader outpatient speech-language pathology benefit, which means your documentation has to carry the full weight of medical necessity.

Quick-Reference Table

CMS Melodic Intonation Therapy Coverage Criteria and Medical Necessity Requirements 2026

The CMS melodic intonation therapy coverage policy under NCD 89 sets a high bar — intentionally. The Centers for Medicare & Medicaid Services covers melodic intonation therapy only when two conditions are both true.

First, the patient must be a nonfluent aphasic patient. This isn't just any aphasia diagnosis. Nonfluent aphasia — think Broca's aphasia, transcortical motor aphasia — involves reduced verbal output and effortful speech. Fluent aphasia presentations do not qualify under this policy.

Second, the patient must be unresponsive to conventional therapy. The policy language is explicit: conventional speech therapy must have already been tried and must have failed to produce meaningful improvement. A patient who hasn't yet received standard aphasia treatment doesn't meet criteria, regardless of severity.

If both conditions are met, coverage also requires that the general conditions for Medicare outpatient speech-language pathology services are satisfied. That means the service must be medically necessary, provided by or under the supervision of a qualified speech-language pathologist, and documented according to the Medicare Benefit Policy Manual, Chapter 15, §§220.1 and 230.6.

Medical necessity documentation here is not a formality — it's the difference between payment and denial. Your chart needs to show the diagnosis of nonfluent aphasia, the prior treatments attempted, the duration and nature of those treatments, and why the patient failed to progress. A generic plan of care with "aphasia" as the diagnosis will not survive a post-payment audit.

Prior authorization is not explicitly required under this NCD, but that doesn't mean you're in the clear. Some Medicare Advantage plans have their own prior authorization requirements for speech-language pathology services, and their coverage policy may differ from traditional Medicare's NCD. Check each plan's specific requirements before assuming NCD 89 applies directly.

Whether melodic intonation therapy is covered under Medicare comes down to documentation discipline. The clinical criteria are manageable. The billing execution is where most denials happen.

Coverage Indications at a Glance

CMS Melodic Intonation Therapy Exclusions and Non-Covered Indications

CMS does not cover melodic intonation therapy as a first-line treatment for any aphasia type. The policy language is unambiguous on this. The therapy exists in the coverage framework as a last-resort option — not a standard of care.

Fluent aphasia is a hard exclusion. Patients with Wernicke's aphasia, conduction aphasia, or anomic aphasia who have intact verbal output do not meet the nonfluent patient criterion. Billing melodic intonation therapy for these patients is a claim denial waiting to happen.

The policy also notes that the supporting research base is limited — "limited studies by a few institutions show some benefit for a small number" of qualifying patients. CMS is not treating this as an evidence-backed standard therapy. They're covering it narrowly, for a narrow population, with explicit conditions attached. Interpret the coverage indications conservatively.

CMS Melodic Intonation Therapy Billing Guidelines and Action Items 2026

Melodic intonation therapy billing under NCD 89 requires precision. The policy doesn't list specific CPT or HCPCS codes, so your billing team is working within the broader outpatient SLP framework. That creates documentation and coding responsibility that sits squarely with your clinical and billing staff.

Here's what to do before and after the March 7, 2026 effective date:

If your program has significant volume in aphasia rehabilitation, loop in your compliance officer before the March 7, 2026 effective date. The intersection of narrow coverage criteria and no specified procedure codes creates real reimbursement exposure if documentation isn't tight.

CPT, HCPCS, and ICD-10 Codes for Melodic Intonation Therapy Under NCD 89

NCD 89 does not list specific CPT, HCPCS, or ICD-10 codes. This is not unusual for older NCDs that predate modern code-specific policy formats — but it creates real billing complexity.

What the Absence of Codes Means for Your Team

Without assigned CPT or HCPCS codes, melodic intonation therapy is billed using the standard outpatient speech-language pathology procedure codes that apply to the service provided. Your coding team should work with the supervising SLP to identify the appropriate code based on the actual service delivered — individual speech therapy, evaluation, or re-evaluation — rather than a therapy-specific code.

The NCD coverage criteria apply at the claim review level, not the code level. That means a claim for a routine SLP procedure code can be denied if a post-payment reviewer determines the underlying service was melodic intonation therapy and the documentation doesn't support the NCD 89 criteria. Code selection doesn't insulate you from coverage policy scrutiny.

Recommended Documentation Practice

Since no codes are specified in NCD 89, your defense lives entirely in the medical record and the claim narrative. Document the technique used (melodic intonation therapy by name), the diagnosis (nonfluent aphasia), and the prior treatment history — every time. Don't assume a reviewer will connect the dots from a generic code and a generic diagnosis.